IONS
NASDAQStockIonis Pharmaceuticals, Inc.
$72.52-2.31 (-3.09%)
52-Week Range
$25.51
$86.50
Key Stats
Market Cap
12.0B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.36
Volume
1.3M
Avg Volume
2.6M
Performance
1M
-14.24%
3M
-9.30%
6M
+18.40%
YTD
-9.20%
1Y
+119.88%
3Y
+114.28%
5Y
+32.44%
Price Chart
ETF Exposure
IONS is held by 145 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.02% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.02% |
| IWB | iShares Russell 1000 ETF | 0.02% |
| RECS | Columbia Research Enhanced Core ETF | 0.02% |
| SCHB | Schwab U.S. Broad Market ETF | 0.02% |
| SCHK | Schwab 1000 Index ETF | 0.02% |
| IWV | iShares Russell 3000 ETF | 0.02% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% |
| IALT | iShares Systematic Alternatives Active ETF | 0.01% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.01% |
| VT | Vanguard Total World Stock ETF | 0.01% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.01% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.01% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.01% |
| JHML | John Hancock Investments - Multifactor Large Cap ETF | 0.01% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.01% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.01% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.01% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.01% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.01% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| GVUS | Goldman Sachs MarketBeta Russell 1000 Value Equity ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| IWD | iShares Russell 1000 Value ETF | 0.00% |
| VONV | Vanguard Russell 1000 Value ETF | 0.00% |
| XCHG | Alliance Bernstein - AB US Equity ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| REVS | Columbia Research Enhanced Value ETF | 0.00% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| LRND | NYLI U.S. Large Cap R&D Leaders ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 3 of 3
About IONS ETF Exposure
Ionis Pharmaceuticals, Inc. (IONS) is held by 145 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 12.0B, IONS is a widely held institutional stock. The stock currently trades at $72.52. Investors can gain exposure to IONS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IONS, sorted by portfolio weight.